The regulator's perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future?
| Image |  |
|---|---|
| Description | scientific article published on August 2016 |
| Author/s |
author: Jana Lízrová Preiningerová Claire M. B. Holloway Beatriz Silva Lima |
| Publication date | August 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |